We are live on
!
Find out more
CCMW
Cypress Capital Management (Wyoming) Portfolio holdings
AUM
$108M
1-Year Est. Return
54.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.39%
1 Year Est. Return
+54.47%
3 Year Est. Return
+138.31%
5 Year Est. Return
+183.27%
10 Year Est. Return
+648.96%
AUM
$95.3M
AUM Growth
+$8.13M
(+9.3%)
Cap. Flow
+$6.75M
Cap. Flow
% of AUM
7.08%
Top 10 Holdings %
Top 10 Hldgs %
30.95%
Holding
359
New
50
Increased
60
Reduced
67
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$1.88M |
| 2 |
Edwards Lifesciences
EW
|
+$1.68M |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$1.49M |
| 4 |
TVRD
Tvardi Therapeutics
TVRD
|
+$1.05M |
| 5 |
CRZO
Carrizo Oil & Gas Inc
CRZO
|
+$988K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$1.66M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.39M |
| 3 |
CELG
Celgene Corp
CELG
|
+$813K |
| 4 |
British American Tobacco
BTI
|
+$539K |
| 5 |
Lantheus
LNTH
|
+$389K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Consumer Staples | 9.34% |
| 3 | Industrials | 8.6% |
| 4 | Healthcare | 8.24% |
| 5 | Financials | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.54T
| $5.58M | 5.86% |
120,612
-2,952
| -2% | -$134K |
|
2
Schwab US Large- Cap ETF
SCHX
$71.8B
| $4.05M | 4.24% |
373,500
-16,020
| -4% | -$173K |
|
3
NVIDIA
NVDA
$4.86T
| $3.75M | 3.93% |
633,200
+51,600
| +9% | +$313K |
|
4
Micron Technology
MU
$930B
| $2.63M | 2.76% |
50,202
+8,057
| +19% | +$436K |
|
5
Schwab US Mid-Cap ETF
SCHM
$14.5B
| $2.54M | 2.67% |
138,975
-12,090
| -8% | -$219K |
|
|
6
Altria Group
MO
$114B
| $2.42M | 2.54% |
42,675
-28,725
| -40% | -$1.66M |
|
7
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $2.42M | 2.54% |
28,994
-335
| -1% | -$27.8K |
|
8
Schwab U.S Small- Cap ETF
SCHA
$22.2B
| $2.04M | 2.14% |
110,920
-11,780
| -10% | -$213K |
|
|
SCHV
9
Schwab US Large-Cap Value ETF
SCHV
$15.7B
| $2.03M | 2.13% |
114,855
+510
| +0.4% | +$9.1K |
|
|
10
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.65B
| $2.03M | 2.13% |
11,790
+11,665
| +9,332% | +$1.88M |
|
|
11
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
| $1.94M | 2.03% |
204,688
+159,696
| +355% | +$1.49M |
|
|
VGR
12
DELISTED
Vector Group Ltd.
VGR
| $1.81M | 1.9% |
147,193
-8,356
| -5% | -$105K |
|
|
13
Edwards Lifesciences
EW
$49.6B
| $1.74M | 1.83% |
+35,925
| New | +$1.68M |
|
14
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $1.59M | 1.67% |
45,770
-200
| -0.4% | -$6.86K |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $1.58M | 1.66% |
19,944
-9,787
| -33% | -$813K |
|
16
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $1.54M | 1.62% |
40,885
-2,380
| -6% | -$88.6K |
|
17
Boise Cascade
BCC
$2.69B
| $1.5M | 1.58% |
33,680
+4,755
| +16% | +$209K |
|
18
VanEck Gold Miners ETF
GDX
$22.7B
| $1.48M | 1.55% |
66,235
+10,050
| +18% | +$225K |
|
|
TVRD
19
Tvardi Therapeutics
TVRD
$19.7M
| $1.43M | 1.5% |
+2,068
| New | +$1.05M |
|
20
MasTec
MTZ
$21.1B
| $1.38M | 1.45% |
27,235
+950
| +4% | +$45.9K |
|
21
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $1.31M | 1.38% |
49,435
+1,900
| +4% | +$52.4K |
|
22
Philip Morris
PM
$297B
| $1.3M | 1.36% |
16,050
-620
| -4% | -$52.6K |
|
23
Chemours
CC
$2.5B
| $1.29M | 1.36% |
29,141
-209
| -0.7% | -$10.4K |
|
24
Constellation Brands
STZ
$22.2B
| $1.23M | 1.29% |
5,596
-75
| -1% | -$16.9K |
|
|
CRZO
25
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $1.19M | 1.25% |
+42,815
| New | +$988K |
|
Similar funds
GCCM
PCC
PFG
IPS
FA
HPM
SFAM
HSM
Cypress Capital Management (Wyoming)'s Q2 2018 Portfolio in Review
As of Q2 2018, Cypress Capital Management (Wyoming) held 359 positions worth $95.3M, up 9.3% from $87.2M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Cypress Capital Management (Wyoming) deployed $6.75M of net new capital in Q2 2018, opening 50 new positions and adding to 60 existing holdings. Its largest new stake was Edwards Lifesciences: 35,925 shares worth $1.74M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Industrials.
On the sell side, the largest reduction was Altria Group, an estimated $1.66M trimmed.
- Cypress Capital Management (Wyoming)'s largest Q2 2018 buy was Edwards Lifesciences: 35,925 shares worth $1.74M.
- Cypress Capital Management (Wyoming) added most to State Street SPDR S&P Oil & Gas Exploration & Production ETF in Q2 2018, an estimated $1.88M increase.
- Cypress Capital Management (Wyoming)'s biggest Q2 2018 reduction was Altria Group, cutting an estimated $1.66M.
- Cypress Capital Management (Wyoming) fully exited Lantheus in Q2 2018, selling an estimated $389K.
- Cypress Capital Management (Wyoming)'s ten largest holdings make up 31% of its $95.3M portfolio in Q2 2018.
- Cypress Capital Management (Wyoming) opened 50 new positions and closed 38 in Q2 2018.
- Cypress Capital Management (Wyoming)'s portfolio value rose 9.3% quarter-over-quarter to $95.3M.
Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2018, filed 8 Aug 2018.